Verenium and Add Food Service GmbH Announce Commercial Distribution Partnership for Fuelzyme(R) and Veretase(T...( Fuelzyme alpha amylase is a unique hi...),Health

Fuelzyme alpha amylase is a unique high performance enzyme designed to significantly improve the efficiency and economics of fuel ethanol production. Fuelzyme provides exceptional mash viscosity reduction, at a much lower dose, compared to competitive products and is effective over an exceptionally wide temperature and pH range allowing ethanol producers greater operational flexibility. Fuelzyme is an extremely thermostable alpha amylase with a unique mode of action for starch breakdown enabling ethanol producers to achieve significant enzyme dose reductions resulting in sizeable enzyme cost savings. Furthermore, the ability of Fuelzyme to effectively perform mash liquefaction at a much lower pH than competitor products can reduce chemical usage.

About Veretase Alpha Amylase

Veretase alpha amylase is a high performance enzyme designed to significantly improve the efficiency and economics of sweetener and beverage alcohol production. With a unique mode of action this enzyme breaks down starch into a more uniform blend of lower molecular weight oligosaccharides, improving saccharification and fermentation efficiency and consistency. Veretase possesses extreme thermostability and low pH activity, and has been shown to be effective over an exceptionally wide temperature and pH range providing sweetener and beverage alcohol producers greater operational flexibility and reduced processing costs. Veretase also provides exceptional mash viscosity reduction at a much lower dose over competitive products.

About Verenium

Verenium Corporation is a leader in the development and commercialization of cellulosic ethanol, an environmentally-friendly and renewable transportation fuel, as well as high-performance specialty enzymes for applications within the biofuels, industrial, and animal health markets. The Company possesses integrated, end-to-end capabilities and cutting-edge technology in pre-treatment, novel
'/>"/>